전산화단층촬영을 시행받는 응급환자에서 조영제 유도 신독성 예방을 위한 저용량 아세틸시스테인 정맥투여 = Low-dose Intravenous N-acetylcysteine for the Prevention of Contrast-Induced Nephropathy in Emergency Patients Undergoing Computed Tomography

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the effects of low-dose intravenous N-acetylcysteine on the prevention of contrast-induced nephropathy (CIN) in patients undergoing computed tomography (CT).
Methods: All patients presenting to our emergency department and undergoing CT with intravenous contrast media between August 2014 and April 2016 were retrospectively enrolled. We included hospitalized patients with renal dysfunction [estimated glomerular filtration rate (GFR) between 30 and 89 mL/min/1.73 ㎡]. A 600-mg injection of Nacetylcysteine was given to patients once before and once immediately after CT, depending on the preference of physician. The primary outcome was CIN defined as an increase in creatinine level of ≥25% or ≥0.5 mg/dL from the baseline within 48 to 72 hours after CT. A trained person blindly reviewed all medical records.
Results: Of the 1903 admitted patients, CIN occurred in 9.8% of patients who received 1200 mg intravenous Nacetylcysteine (24/244) and 6.8% of patients who did not (113/1659, p=0.090). In a multivariable regression analysis, N-acetylcystine was not relevant to the prevention of CIN (odds ratio=1.42 [95% CI, 0.90-2.26]). Even in the stratified analysis using the propensity score matching, N-acetylcysteine was irrelevant (GFR 30-59: odds ratio=1.06 [95% CI, 0.43-2.60]; GFR 60-89: odds ratio=1.76 [95% CI, 0.75-4.14]). After adjustment, crystalloids were significantly associated with the reduction in CIN compared with dextrose water (odds ratio=0.60 [95% CI, 0.37-0.97]).
Conclusion: No effect was found when low-dose intravenous N-acetylcysteine was used to prevent CIN. However, there seems to be an association between crystalloids and reduction in CIN.

참고문헌 (Reference)

1 Wu MY, "The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a metaanalysis of randomized controlled trials" 45 : 1309-1318, 2013

2 Hinson JS, "Risk of Acute Kidney Injury After Intravenous Contrast Media Administration" 69 : 577-586, 2017

3 Toprak O, "Risk markers for contrast-induced nephropathy" 334 : 283-290, 2007

4 Tepel M, "Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine" 343 : 180-184, 2000

5 Kocher KE, "National trends in use of computed tomography in the emergency department" 58 : 452-462, 2011

6 Traub SJ, "N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography" 62 : 511-520, 2013

7 Fishbane S, "N-acetylcysteine in the prevention of radiocontrast-induced nephropathy" 15 : 251-260, 2004

8 Hsu TF, "N-acetylcysteine for the prevention of contrastinduced nephropathy in the emergency department" 51 : 2709-2714, 2012

9 Shalansky SJ, "N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?" 25 : 1095-1103, 2005

10 Marenzi G, "N-acetylcysteine and contrast-induced nephropathy in primary angioplasty" 354 : 2773-2782, 2006

11 DiMari J, "N-acetyl cysteine ameliorates ischemic renal failure" 272 : F292-F298, 1997

12 Dittrich R, "Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients" 254 : 1491-1497, 2007

13 Kidney Disease: Improving Global Outcomes (KDIGO)Acute Kidney Injury Work Group, "KDIGO Clinical Practice Guideline for Acute Kidney Injury" 2 : 1-138, 2012

14 "K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification" 39 : S1-S266, 2002

15 Poletti PA, "IV N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity" 189 : 687-692, 2007

16 Subramaniam RM, "Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis" 164 : 406-416, 2016

17 Gleeson TG, "Contrast-induced nephropathy" 183 : 1673-1689, 2004

18 Wichmann JL, "Contrast-Induced Nephropathy" 132 : 1931-1936, 2015

19 McCullough PA, "Contrast-Induced Acute Kidney Injury" 68 : 1465-1473, 2016

20 Barrett BJ, "Clinical practice. Preventing nephropathy induced by contrast medium" 354 : 379-386, 2006

21 ACR.org, "American College of Radiology"

22 Levine GN, "ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" 124 : e574-e651, 2011